Sensei Biotherapeutics, Inc.
SNSE
$21.45
$0.452.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.14% | -18.49% | -16.63% | -24.31% | -30.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.98% | -24.56% | -15.25% | -13.66% | -15.03% |
| Operating Income | 34.98% | 24.56% | 15.25% | 13.66% | 15.03% |
| Income Before Tax | 30.08% | 19.00% | 9.60% | 9.05% | 11.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.08% | 19.00% | 9.60% | 9.05% | 11.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.08% | 19.00% | 9.60% | 9.05% | 11.57% |
| EBIT | 34.98% | 24.56% | 15.25% | 13.66% | 15.03% |
| EBITDA | 32.60% | 22.78% | 14.02% | 13.31% | 15.52% |
| EPS Basic | 30.35% | 19.40% | 9.68% | 4.03% | 1.04% |
| Normalized Basic EPS | 33.67% | 21.84% | 12.26% | 6.04% | 3.87% |
| EPS Diluted | 30.35% | 19.40% | 9.68% | 4.03% | 1.04% |
| Normalized Diluted EPS | 33.67% | 21.84% | 12.26% | 6.04% | 3.87% |
| Average Basic Shares Outstanding | 0.40% | 0.52% | 0.07% | -5.14% | -10.20% |
| Average Diluted Shares Outstanding | 0.40% | 0.52% | 0.07% | -5.14% | -10.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |